NEO – neogenomics, inc. (US:NASDAQ)
Stock Stats
News
NeoGenomics (NASDAQ:NEO) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
NeoGenomics sees Q4 revenue of about $190M [Seeking Alpha]
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue [Yahoo! Finance]
NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
Form 4 NEOGENOMICS INC For: Jan 13 Filed by: Stone Warren
Form 4 NEOGENOMICS INC For: Jan 13 Filed by: Olivo Alicia C
Form 8-K NEOGENOMICS INC For: Jan 09
Form 4 NEOGENOMICS INC For: Jan 01 Filed by: Kenny John P.
Form 3 NEOGENOMICS INC For: Jan 01 Filed by: Kenny John P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.